Using AI as a tool for creativity Date Thursday, May 09, 2024 - 10:00 PM Description Philosopher and Harvard professor Martin Puchner on harnessing the power of AI for creativity
Using fear to sell AI is a bad idea Date Monday, August 26, 2024 - 10:00 PM Description Constant warnings about the technology’s power primes early users for disappointment
Utah orders A-Cap insurers to cease new business after 777 debacle Date Tuesday, December 03, 2024 - 8:30 AM Description Three US life insurers in ‘hazardous financial condition’ after sports buying spree unravels
Utah’s Republican voters fume over Doge cuts Date Sunday, March 23, 2025 - 4:10 AM Description Representatives in Trump-voting districts try to reassure constituents over Elon Musk’s unpopular federal job cuts
Vaccine alliance battles for funds as donors face financial pressures Date Sunday, September 22, 2024 - 4:00 AM Description Gavi chief Sania Nishtar offers rich nations long-term payment options for life-saving jabs
Vaccine billionaire to pay £138mn for London mansion Date Monday, December 11, 2023 - 2:00 PM Description Adar Poonawalla strikes biggest home sale of the year in UK capital with deal for Mayfair property
Vaccine bottlenecks threaten to hamper response to Mpox emergency Date Thursday, August 15, 2024 - 10:51 AM Description Leading producer says it needs orders to ramp up supply as cases surge in central and east Africa
Vaccine investment is a no-brainer — so why aren’t we doing it? Date Friday, March 29, 2024 - 11:00 PM Description Not only is the cost-benefit ratio unbeatable, but not to undertake this spending is to court disaster
Vaccine makers’ shares jump after bird flu death in US Date Tuesday, January 07, 2025 - 11:18 AM Description Moderna, Pfizer, CureVac and Novavax register gains as health agency stresses risk to public ‘remains low’
Vaccine stocks hit by RFK Jr nomination Date Friday, November 15, 2024 - 10:22 AM Description GSK, Sanofi and Moderna shares all sink after Donald Trump chooses vaccine sceptic as top US health official